2018

Callendret B, Vellinga J, Wunderlich K, Rodriguez A, Steigerwald R, Dirmeier U, Cheminay C, Volkmann A, Brasel T, Carrion R, Giavedoni LD, Patterson JL, Mire CE, Geisbert TW, Hooper JW, Weijtens M, Hartkoorn-Pasma J, Custers J, Grazia Pau M, Schuitemaker H, Zahn R
A prophylactic multivalent vaccine against different filovirus species isimmunogenic and provides protection from lethal infections with Ebolavirus and Marburgvirus species in non-human primates.
PLoS One. 2018 Feb 20;13(2):e0192312. doi: 10.1371/journal.pone.0192312.eCollection 2018. 2018.

2017

Du K, Cai H, Park M, Wall TA, Stott MA, Alfson KJ, Griffiths A, Carrion R, Patterson JL, Hawkins AR, Schmidt H, Mathies RA
Multiplexed efficient on-chip sample preparation and sensitive amplification-freedetection of Ebola virus.
Biosens Bioelectron. 2017 May 15;91:489-496. doi: 10.1016/j.bios.2016.12.071.Epub 2017 Jan 3. 2017.

Iampietro M, Younan P, Nishida A, Dutta M, Lubaki NM, Santos RI, Koup RA, Katze MG, Bukreyev A
Ebola virus glycoprotein directly triggers T lymphocyte death despite of the lackof infection.
PLoS Pathog. 2017 May 22;13(5):e1006397. doi: 10.1371/journal.ppat.1006397.eCollection 2017 May. 2017.

Yi F, Guo J, Dabbagh D, Spear M, He S, Kehn-Hall K, Fontenot J, Yin Y, Bibian M, Park CM, Zheng K, Park HJ, Soloveva V, Gharaibeh D, Retterer C, Zamani R, Pitt ML, Naughton J, Jiang Y, Shang H, Hakami RM, Ling B, Young JAT, Bavari S, Xu X, Feng Y, Wu Y
Discovery of Novel Small-Molecule Inhibitors of LIM Domain Kinase for Inhibiting HIV-1.
J Virol. 2017 Jun 9;91(13). pii: JVI.02418-16. doi: 10.1128/JVI.02418-16. Print2017 Jul 1. 2017.

Younan P, Iampietro M, Nishida A, Ramanathan P, Santos RI, Dutta M, Lubaki NM, Koup RA, Katze MG, Bukreyev A
Ebola Virus Binding to Tim-1 on T Lymphocytes Induces a Cytokine Storm.
MBio. 2017 Sep 26;8(5). pii: mBio.00845-17. doi: 10.1128/mBio.00845-17. 2017.

2016

Cap AP, Pidcoke HF, Keil SD, Staples HM, Anantpadma M, Carrion R Jr, Davey RA, Frazer-Abel A, Taylor AL, Gonzales R, Patterson JL, Goodrich RP
Treatment of blood with a pathogen reduction technology using ultraviolet lightand riboflavin inactivates Ebola virus in vitro.
Transfusion. 2016 Mar;56 Suppl 1:S6-15. doi: 10.1111/trf.13393. 2016.

Theiler J, Yoon H, Yusim K, Picker LJ, Fruh K, Korber B
Epigraph: A Vaccine Design Tool Applied to an HIV Therapeutic Vaccine and aPan-Filovirus Vaccine.
Sci Rep. 2016 Oct 5;6:33987. doi: 10.1038/srep33987. 2016.

2015

Alfson KJ, Avena LE, Beadles MW, Menzie H, Patterson JL, Carrion R Jr, Griffiths A
Genetic Changes at the Glycoprotein Editing Site Associated With Serial Passageof Sudan Virus.
J Infect Dis. 2015 Oct 1;212 Suppl 2:S295-304. doi: 10.1093/infdis/jiv216. Epub2015 Apr 28. 2015.

Alfson KJ, Avena LE, Beadles MW, Staples H, Nunneley JW, Ticer A, Dick EJ Jr, Owston MA, Reed C, Patterson JL, Carrion R Jr, Griffiths A
Particle-to-PFU ratio of Ebola virus influences disease course and survival incynomolgus macaques.
J Virol. 2015 Jul;89(13):6773-81. doi: 10.1128/JVI.00649-15. 2015.

Alfson KJ, Worwa G, Carrion R Jr, Griffiths A
Determination and Therapeutic Exploitation of Ebola Virus Spontaneous MutationFrequency.
J Virol. 2015 Dec 16;90(5):2345-55. doi: 10.1128/JVI.02701-15. 2015.

Barrenas F, Green RR, Thomas MJ, Law GL, Proll SC, Engelmann F, Messaoudi I, Marzi A, Feldmann H, Katze MG
Next-generation sequencing reveals a controlled immune response to Zaire Ebolavirus challenge in cynomolgus macaques immunized with vesicular stomatitis virus expressing Zaire Ebola virus glycoprotein (VSVDeltaG/EBOVgp).
Clin Vaccine Immunol. 2015 Mar;22(3):354-6. doi: 10.1128/CVI.00733-14. Epub 2015 Jan 14. 2015.

Cai H, Parks JW, Wall TA, Stott MA, Stambaugh A, Alfson K, Griffiths A, Mathies RA, Carrion R, Patterson JL, Hawkins AR, Schmidt H
Optofluidic analysis system for amplification-free, direct detection of Ebolainfection.
Sci Rep. 2015 Sep 25;5:14494. doi: 10.1038/srep14494. 2015.

Cai Y, Postnikova EN, Bernbaum JG, Yu SQ, Mazur S, Deiuliis NM, Radoshitzky SR, Lackemeyer MG, McCluskey A, Robinson PJ, Haucke V, Wahl-Jensen V, Bailey AL, Lauck M, Friedrich TC, O'Connor DH, Goldberg TL, Jahrling PB, Kuhn JH
Simian hemorrhagic fever virus cell entry is dependent on CD163 and uses aclathrin-mediated endocytosis-like pathway.
J Virol. 2015 Jan;89(1):844-56. doi: 10.1128/JVI.02697-14. Epub 2014 Oct 29. 2015.

Gustin JK, Bai Y, Moses AV, Douglas JL
Ebola Virus Glycoprotein Promotes Enhanced Viral Egress by Preventing Ebola VP40 From Associating With the Host Restriction Factor BST2/Tetherin.
J Infect Dis. 2015 Oct 1;212 Suppl 2:S181-90. doi: 10.1093/infdis/jiv125. Epub2015 Mar 27. 2015.

Lauck M, Bailey AL, Andersen KG, Goldberg TL, Sabeti PC, O'Connor DH
GB virus C coinfections in west African Ebola patients.
J Virol. 2015 Feb;89(4):2425-9. doi: 10.1128/JVI.02752-14. Epub 2014 Dec 3. 2015.

Ma DY, Suthar MS
Mechanisms of innate immune evasion in re-emerging RNA viruses.
Curr Opin Virol. 2015 Jun;12:26-37. doi: 10.1016/j.coviro.2015.02.005. Epub 2015 Mar 9. 2015.

Mandl JN, Ahmed R, Barreiro LB, Daszak P, Epstein JH, Virgin HW, Feinberg MB
Reservoir host immune responses to emerging zoonotic viruses.
Cell. 2015 Jan 15;160(1-2):20-35. doi: 10.1016/j.cell.2014.12.003. Epub 2014 Dec 18. 2015.

Messaoudi I, Basler CF
Immunological features underlying viral hemorrhagic fevers.
Curr Opin Immunol. 2015 Oct;36:38-46. doi: 10.1016/j.coi.2015.06.003. Epub 2015Jul 7. 2015.

Okumura A, Rasmussen AL, Halfmann P, Feldmann F, Yoshimura A, Feldmann H, Kawaoka Y, Harty RN, Katze MG
Suppressor of Cytokine Signaling 3 Is an Inducible Host Factor That RegulatesVirus Egress during Ebola Virus Infection.
J Virol. 2015 Oct;89(20):10399-406. doi: 10.1128/JVI.01736-15. Epub 2015 Aug 5. 2015.

2014

Peng X, Pipes L, Xiong H, Green RR, Jones DC, Ruzzo WL, Schroth GP, Mason CE, Palermo RE, Katze MG
Assessment and improvement of Indian-origin rhesus macaque and Mauritian-origincynomolgus macaque genome annotations using deep transcriptome sequencing data.
J Med Primatol. 2014 Oct;43(5):317-28. doi: 10.1111/jmp.12125. Epub 2014 May 8. 2014.

Rasmussen AL, Okumura A, Ferris MT, Green R, Feldmann F, Kelly SM, Scott DP, Safronetz D, Haddock E, LaCasse R, Thomas MJ, Sova P, Carter VS, Weiss JM, Miller DR, Shaw GD, Korth MJ, Heise MT, Baric RS, de Villena FP, Feldmann H, Katze MG
Host genetic diversity enables Ebola hemorrhagic fever pathogenesis andresistance.
Science. 2014 Nov 21;346(6212):987-91. doi: 10.1126/science.1259595. Epub 2014Oct 30. 2014.

Tchitchek N, Safronetz D, Rasmussen AL, Martens C, Virtaneva K, Porcella SF, Feldmann H, Ebihara H, Katze MG
Sequencing, annotation and analysis of the Syrian hamster (Mesocricetus auratus) transcriptome.
PLoS One. 2014 Nov 14;9(11):e112617. doi: 10.1371/journal.pone.0112617.eCollection 2014. 2014.

2013

Marzi A, Engelmann F, Feldmann F, Haberthur K, Shupert WL, Brining D, Scott DP, Geisbert TW, Kawaoka Y, Katze MG, Feldmann H, Messaoudi I
Antibodies are necessary for rVSV/ZEBOV-GP-mediated protection against lethalEbola virus challenge in nonhuman primates.
Proc Natl Acad Sci U S A. 2013 Jan 29;110(5):1893-8. doi:10.1073/pnas.1209591110. Epub 2013 Jan 14. 2013.

2011

Basu A, Li B, Mills DM, Panchal RG, Cardinale SC, Butler MM, Peet NP, Majgier-Baranowska H, Williams JD, Patel I, Moir DT, Bavari S, Ray R, Farzan MR, Rong L, Bowlin TL
Identification of a small-molecule entry inhibitor for filoviruses.
J Virol. 2011 Apr;85(7):3106-19. doi: 10.1128/JVI.01456-10. Epub 2011 Jan 26. 2011.

Carrion R Jr, Ro Y, Hoosien K, Ticer A, Brasky K, de la Garza M, Mansfield K, Patterson JL
A small nonhuman primate model for filovirus-induced disease.
Virology. 2011 Nov 25;420(2):117-24. doi: 10.1016/j.virol.2011.08.022. Epub 2011 Sep 28. 2011.

Cilloniz C, Ebihara H, Ni C, Neumann G, Korth MJ, Kelly SM, Kawaoka Y, Feldmann H, Katze MG
Functional genomics reveals the induction of inflammatory response andmetalloproteinase gene expression during lethal Ebola virus infection.
J Virol. 2011 Sep;85(17):9060-8. doi: 10.1128/JVI.00659-11. Epub 2011 Jul 6. 2011.

Huang IC, Bailey CC, Weyer JL, Radoshitzky SR, Becker MM, Chiang JJ, Brass AL, Ahmed AA, Chi X, Dong L, Longobardi LE, Boltz D, Kuhn JH, Elledge SJ, Bavari S, Denison MR, Choe H, Farzan M
Distinct patterns of IFITM-mediated restriction of filoviruses, SARS coronavirus,and influenza A virus.
PLoS Pathog. 2011 Jan 6;7(1):e1001258. doi: 10.1371/journal.ppat.1001258. 2011.

Radoshitzky SR, Warfield KL, Chi X, Dong L, Kota K, Bradfute SB, Gearhart JD, Retterer C, Kranzusch PJ, Misasi JN, Hogenbirk MA, Wahl-Jensen V, Volchkov VE, Cunningham JM, Jahrling PB, Aman MJ, Bavari S, Farzan M, Kuhn JH
Ebolavirus delta-peptide immunoadhesins inhibit marburgvirus and ebolavirus cell entry.
J Virol. 2011 Sep;85(17):8502-13. doi: 10.1128/JVI.02600-10. Epub 2011 Jun 22. 2011.

Tsuda Y, Caposio P, Parkins CJ, Botto S, Messaoudi I, Cicin-Sain L, Feldmann H, Jarvis MA
A replicating cytomegalovirus-based vaccine encoding a single Ebola virusnucleoprotein CTL epitope confers protection against Ebola virus.
PLoS Negl Trop Dis. 2011 Aug;5(8):e1275. doi: 10.1371/journal.pntd.0001275. Epub 2011 Aug 9. 2011.

Viswanathan K, Smith MS, Malouli D, Mansouri M, Nelson JA, Fruh K
BST2/Tetherin enhances entry of human cytomegalovirus.
PLoS Pathog. 2011 Nov;7(11):e1002332. doi: 10.1371/journal.ppat.1002332. Epub2011 Nov 3. 2011.

Wahl-Jensen V, Kurz S, Feldmann F, Buehler LK, Kindrachuk J, DeFilippis V, da Silva Correia J, Fruh K, Kuhn JH, Burton DR, Feldmann H
Ebola virion attachment and entry into human macrophages profoundly effects earlycellular gene expression.
PLoS Negl Trop Dis. 2011 Oct;5(10):e1359. doi: 10.1371/journal.pntd.0001359. Epub2011 Oct 18. 2011.